Elan Outlines Spending Plan

Irish drug maker Elan said it would return $1 billion to shareholders, refinance debt and make acquisitions after the $3.25 billion sale of its stake in a multiple sclerosis drug to Biogen Idec.

Topics:  elan   biogen   idec   billion   drug   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News